Our Medicines

Focusing on patient needs

Takeda’s top priority is the health of Canadians. We are focused on patient needs. Their well-being is central to our work and drives our commitment to deliver a diverse portfolio of innovative treatments.
 
Current important medicines available to Canadians from Takeda Canada include:
 
IMPORTANT NOTE:

As of March 1, 2016, Takeda’s respiratory products were divested to AstraZeneca. For information about the following former Takeda Canada products, please contact AstraZeneca Canada:

         - ALVESCO® (ciclesonide inhalation aerosol)
         - DAXAS® (roflumilast film-coated tablets)
         - OMNARIS® (ciclesonide nasal spray)
 

 

ACTOS®
pioglitazone hydrochloride

 

Product Monograph

Health Care Professional Information:

Patient Information:

 

 

DEXILANT® 
dexlansoprazole

 

 Product Monograph

 

 

ENTYVIO™ 
vedolizumab

 

 Product Monograph 

 

KAZANO™
alogliptin (as alogliptin benzoate) and metformin hydrochloride

 

 Product Monograph 

 

 

NESINA®
alogliptin (as alogliptin benzoate)

 

Product Monograph

 

 

 

NINLARO™
ixazomib (as ixazomib citrate)

 

 

Product Monograph

 

ONDISSOLVE™
ondansetron

 

 

Product Monograph

 

 

PANTOLOC®
pantoprazole sodium

 

 Product Monograph

 

PANTO®IV
Pantoprazole sodium also comes in an intravenous formulation known as PANTO®IV

 

 

 

 

 Product Monograph

 

 

 

 

TACHOSIL® 
Absorbable fibrin sealant patch

 

Product Monograph 

 

 

TECTA®
pantoprazole magnesium

 

Product Monograph 

 

 

ULORIC®
febuxostat

 

Product Monograph

 

 

ACTOS® is a registered trademark of Takeda Pharmaceutical Company Limited and used under licence by Takeda Canada Inc.
DEXILANT® is a trademark of Takeda Pharmaceuticals U.S.A., Inc and used under licence by Takeda Canada Inc.
ENTYVIO® is a registered trademark of Millennium Pharmaceuticals, Inc. and used under licence by Takeda Canada Inc.
KAZANO™ is a trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Canada Inc.
NESINA® is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Canada Inc.
NINLARO™ is a trademark of Millennium Pharmaceuticals, Inc. and used under licence by Takeda Canada Inc.
ONDISSOLVE® is a registered trademark of Takeda GmbH. Used under license.
PANTOLOC®PANTO® IV and TECTA® are registered trademarks of Takeda GmbH. Used under licence.
TACHOSIL® is a registered trademark of Takeda Pharma AS. Used under licence.
ULORIC® is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc. and used under licence by Takeda Canada Inc.

 

Contact Information

For all contact information, including to report an adverse event or for medical information, click here.

Takeda Pharma